Thirteen patients with rheumatoid arthritis (mean & SD age 55.8 f 10.5 years) received 20 mg of tenoxicam daily for 90 days following a 3-7-day "washout" period and 4 days of placebo treatment. Clinical evaluations were conducted at the end of the washout period and at monthly intervals thereafter.
Effect of One-Month Treatment with Nonsteroidal Antiinflammatory Drugs (NSAIDs) on Gastric pH of Rheumatoid Arthritis Patients
β Scribed by Vincenzo Savarino; Giuseppe Sandro; Mela Patrizia Zentilin; Marco Amedeo Cimmino; Maria Parisi; Maria Raffaella Mele; Monica Pivari; Giuliana Bisso; Guido Celle
- Book ID
- 110377037
- Publisher
- Springer US
- Year
- 1998
- Tongue
- English
- Weight
- 108 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We examined the effect of treatment with piroxicam, a nonsteroidal antiinflammatory drug (NSAID), on immunoglobulin (Ig) and IgM-rheumatoid factor (IgM-RF) synthesis in vitro by lymphocytes of patients with rheumatoid arthritis (RA). Oral treatment with piroxicam induced a progressive decrease of sp
## Abstract Clinical, laboratory, genetic, and radiologic studies were evaluated for 18 patients with rheumatoid arthritis who were treated for a mean of 16.6 months with a regimen involving supplementary aspirin and piroxicam, an investigational, nonsteroidal antiinflammatory agent. Although impro